ArticleJournal of hepatocellular carcinoma2025

Efficacy and Safety of Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib for Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven: A Multicentre, Retrospective Propensity Score Matching Analysis.

Sheng Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.